Bernard Daugeras
Gründer bei Auriga Partners SA
Profil
Bernard Daugeras is the founder and currently holds the position of Chairman of the Board at Auriga Partners SA, which was founded in 1998.
He is also currently serving as a Non-Executive Director at Domain Therapeutics SA, Director at Isocell SA, Director at Prophesee SA, Director at IHU Strasbourg, and Member-Supervisory Board at Firalis SA. In the past, Dr. Daugeras has held positions such as Chairman at Sangamo Therapeutics France SAS from 2012 to 2013, Director at Nicox SA, Director at Novagali Pharma SA, Director at MEDIAN Technologies SA, Director at Population Genetics Technologies Ltd., Director at Theranexus SA, Principal at Crédit Lyonnais SA from 1986 to 1990, Principal at the University of California, Berkeley, Member-Supervisory Board at Valerio Therapeutics SA, Member-Supervisory Board at Nemoptic SA, Member-Supervisory Board at INSERM Transfert SA, Researcher at the University of Orsay, and Member-Supervisory Board at SuperSonic Imagine SA from 2005 to 2015.
He has also been a Principal at Finovelec and a Member of the Académie des Technologies.
Additionally, Dr. Daugeras has a doctorate degree from the University of Orsay and an undergraduate degree from Ecole Polytechnique.
Aktive Positionen von Bernard Daugeras
| Unternehmen | Position | Beginn |
|---|---|---|
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Gründer | 12.06.1998 |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Direktor/Vorstandsmitglied | 01.01.2008 |
Isocell SA
 Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - |
Firalis SA
 Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Direktor/Vorstandsmitglied | - |
IHU Strasbourg
 IHU Strasbourg Hospital/Nursing ManagementHealth Services IHU Strasbourg provides medical and surgical center services. The private company is based in Strasbourg, France. | Direktor/Vorstandsmitglied | - |
Prophesee SA
 Prophesee SA Medical SpecialtiesHealth Technology Prophesee SA engages in the development of neuromorphic vision systems. The firm serves clients in autonomous vehicles, industrial automation, IoT, and security and surveillance. The company was founded by Christoph Posch, Ryad Benosman, Luca Verre, and Bernard Jacques Alex Gilly in 2014 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Bernard Daugeras
| Unternehmen | Position | Ende |
|---|---|---|
| SUPERSONIC IMAGINE | Direktor/Vorstandsmitglied | 26.02.2015 |
Crédit Lyonnais SA
 Crédit Lyonnais SA Major BanksFinance Crédit Lyonnais SA provides banking and financial services. Its activities include banking for individuals and professionals, private banking, franchise and associate commerce, and corporate banking and asset management. The company was founded by Henri Germain on July 6, 1863 and is headquartered in Lyon, France. | Corporate Officer/Principal | 01.01.1990 |
| NICOX SA | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Bernard Daugeras
| University of Orsay | Doctorate Degree |
| Ecole Polytechnique | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NICOX SA | Health Technology |
| VALERIO THERAPEUTICS | Health Technology |
| MEDIAN TECHNOLOGIES | Health Services |
| THERANEXUS | Health Technology |
| Private Unternehmen | 16 |
|---|---|
Crédit Lyonnais SA
Crédit Lyonnais SA Major BanksFinance Crédit Lyonnais SA provides banking and financial services. Its activities include banking for individuals and professionals, private banking, franchise and associate commerce, and corporate banking and asset management. The company was founded by Henri Germain on July 6, 1863 and is headquartered in Lyon, France. | Finance |
Auriga Partners SA
Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Finance |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
Nemoptic SA
 Nemoptic SA Electronic Production EquipmentElectronic Technology Nemoptic, an e-paper display company, designs and manufactures superior-quality bistable liquid crystal displays (LCD) modules highly suitable for consumer and professional mobile devices. Unlike other e-paper LCDs in the market, Nemoptic offers a white screen, giving users the best image contrast and a remarkable screen reading experience, comparable to ink on paper. The company's cutting-edge technology, BiNem® (Bistable Nematic), has application in a range of handheld devices, including educational e-books, e-dictionaries, e-newspapers, ultra mobile PCs, mobile phones, toys as well as electronic shelf labels. Nemoptic e-paper displays are recognized for their high resolution, zero-power consumption when holding images, fast-refreshing screens, and low-cost. They come in pure black and white and offer a large number of colors. Nemoptic leads in the development of bendable, full-color rendering e-paper displays. Created in 1999, Nemoptic, headquartered near Paris, has raised more than 46 millions Euros. It operates a pilot line in Sweden and has a license agreement with Seiko Instruments Inc who runs a large-scale production facility in Akita (Japan). | Electronic Technology |
INSERM Transfert SA
 INSERM Transfert SA Investment ManagersFinance INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France. | Finance |
SuperSonic Imagine SA
 SuperSonic Imagine SA Medical SpecialtiesHealth Technology SuperSonic Imagine SA specializes in ultrasound medical imaging. The company designs, develops and markets a new generation ultrasound system, Aixplorer with an UltraFastTM platform that can acquire images faster than conventional ultrasound systems. Its products are used for general imaging, vascular, hepatology, gastroenterology, and research procedures. It operates under the Aixplorer trademark. SuperSonic Imagine was founded by Jacques Souquet, Armen Sarvazyan, Claude Cohen-Bacrie, Damien Dolimier, Georges Charpak, Jérémy Bercoff, Mickaël Tanter, Mathias Fink and Marianne Leven on March 10, 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
| Finovelec | |
Académie des Technologies
 Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Population Genetics Technologies Ltd.
 Population Genetics Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Population Genetics Technologies Ltd. offers population genetics. The firm develops and patents technologies that find, characterize and quantify true genetic variants responsible for disease, disease resistance and drug response for agricultural biotechnology, infectious disease and cancer markets. The company was founded by Sydney Brenner, Sam Eletr, Philip Goelet and Nobel Laureate on April 30, 2004 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Government |
Isocell SA
Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France. | Retail Trade |
Prophesee SA
Prophesee SA Medical SpecialtiesHealth Technology Prophesee SA engages in the development of neuromorphic vision systems. The firm serves clients in autonomous vehicles, industrial automation, IoT, and security and surveillance. The company was founded by Christoph Posch, Ryad Benosman, Luca Verre, and Bernard Jacques Alex Gilly in 2014 and is headquartered in Paris, France. | Health Technology |
IHU Strasbourg
IHU Strasbourg Hospital/Nursing ManagementHealth Services IHU Strasbourg provides medical and surgical center services. The private company is based in Strasbourg, France. | Health Services |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Health Technology |